Annual Cash & Cash Equivalents
$19.84 M
-$32.58 M-62.15%
31 December 2023
Summary:
Assembly Biosciences annual cash & cash equivalents is currently $19.84 million, with the most recent change of -$32.58 million (-62.15%) on 31 December 2023. During the last 3 years, it has fallen by -$39.60 million (-66.62%). ASMB annual cash & cash equivalents is now -75.81% below its all-time high of $82.03 million, reached on 31 December 2017.ASMB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$28.45 M
+$9.24 M+48.13%
30 September 2024
Summary:
Assembly Biosciences quarterly cash and cash equivalents is currently $28.45 million, with the most recent change of +$9.24 million (+48.13%) on 30 September 2024. Over the past year, it has increased by +$1.80 million (+6.74%). ASMB quarterly cash and cash equivalents is now -76.24% below its all-time high of $119.75 million, reached on 30 September 2018.ASMB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.1% | +6.7% |
| 3 y3 years | -66.6% | -59.8% |
| 5 y5 years | -52.2% | +14.4% |
ASMB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.6% | at low | -59.8% | +51.8% |
| 5 y | 5 years | -66.6% | at low | -70.6% | +51.8% |
| alltime | all time | -75.8% | >+9999.0% | -76.2% | >+9999.0% |
Assembly Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.45 M(+48.1%) |
| June 2024 | - | $19.21 M(+2.4%) |
| Mar 2024 | - | $18.75 M(-5.5%) |
| Dec 2023 | $19.84 M(-62.1%) | $19.84 M(-25.6%) |
| Sept 2023 | - | $26.66 M(+23.3%) |
| June 2023 | - | $21.62 M(-50.3%) |
| Mar 2023 | - | $43.48 M(-17.0%) |
| Dec 2022 | $52.42 M(+14.9%) | $52.42 M(-4.1%) |
| Sept 2022 | - | $54.67 M(+27.0%) |
| June 2022 | - | $43.06 M(-15.8%) |
| Mar 2022 | - | $51.17 M(+12.2%) |
| Dec 2021 | $45.63 M(-23.2%) | $45.63 M(-35.5%) |
| Sept 2021 | - | $70.76 M(+18.9%) |
| June 2021 | - | $59.52 M(-23.9%) |
| Mar 2021 | - | $78.25 M(+31.6%) |
| Dec 2020 | $59.44 M(+27.2%) | $59.44 M(+1.9%) |
| Sept 2020 | - | $58.31 M(-39.7%) |
| June 2020 | - | $96.71 M(+128.5%) |
| Mar 2020 | - | $42.33 M(-9.4%) |
| Dec 2019 | $46.73 M(+12.7%) | $46.73 M(+87.9%) |
| Sept 2019 | - | $24.87 M(-27.4%) |
| June 2019 | - | $34.26 M(+17.7%) |
| Mar 2019 | - | $29.11 M(-29.8%) |
| Dec 2018 | $41.47 M(-49.4%) | $41.47 M(-65.4%) |
| Sept 2018 | - | $119.75 M(+121.0%) |
| June 2018 | - | $54.19 M(-19.0%) |
| Mar 2018 | - | $66.93 M(-18.4%) |
| Dec 2017 | $82.03 M | $82.03 M(+201.1%) |
| Sept 2017 | - | $27.25 M(-30.9%) |
| June 2017 | - | $39.45 M(-44.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $70.82 M(+147.8%) |
| Dec 2016 | $28.58 M(+5.4%) | $28.58 M(+20.1%) |
| Sept 2016 | - | $23.79 M(+17.0%) |
| June 2016 | - | $20.34 M(-0.3%) |
| Mar 2016 | - | $20.39 M(-24.8%) |
| Dec 2015 | $27.11 M(-6.8%) | $27.11 M(-25.5%) |
| Sept 2015 | - | $36.40 M(-32.0%) |
| June 2015 | - | $53.52 M(-44.3%) |
| Mar 2015 | - | $96.05 M(+230.2%) |
| Dec 2014 | $29.09 M(+7.5%) | $29.09 M(+62.2%) |
| Sept 2014 | - | $17.93 M(-15.9%) |
| June 2014 | - | $21.32 M(-9.8%) |
| Mar 2014 | - | $23.64 M(-12.7%) |
| Dec 2013 | $27.06 M(+32.1%) | $27.06 M(-16.0%) |
| Sept 2013 | - | $32.22 M(-3.8%) |
| June 2013 | - | $33.49 M(-9.2%) |
| Mar 2013 | - | $36.87 M(+80.0%) |
| Dec 2012 | $20.49 M(-44.6%) | $20.49 M(-13.0%) |
| Sept 2012 | - | $23.56 M(-18.3%) |
| June 2012 | - | $28.84 M(-7.2%) |
| Mar 2012 | - | $31.07 M(-16.0%) |
| Dec 2011 | $36.98 M(+153.8%) | $36.98 M(-30.6%) |
| Sept 2011 | - | $53.29 M(+368.8%) |
| June 2011 | - | $11.37 M(-18.8%) |
| Mar 2011 | - | $14.00 M(-3.9%) |
| Dec 2010 | $14.57 M(>+9900.0%) | $14.57 M(+5274.8%) |
| Sept 2010 | - | $271.10 K(-58.3%) |
| June 2010 | - | $649.70 K(-39.2%) |
| Mar 2010 | - | $1.07 M(+1213.4%) |
| Dec 2009 | $81.30 K(+411.3%) | $81.30 K |
| Dec 2008 | $15.90 K | - |
FAQ
- What is Assembly Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Assembly Biosciences?
- What is Assembly Biosciences annual cash & cash equivalents year-on-year change?
- What is Assembly Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Assembly Biosciences?
- What is Assembly Biosciences quarterly cash and cash equivalents year-on-year change?
What is Assembly Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ASMB is $19.84 M
What is the all time high annual cash & cash equivalents for Assembly Biosciences?
Assembly Biosciences all-time high annual cash & cash equivalents is $82.03 M
What is Assembly Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, ASMB annual cash & cash equivalents has changed by -$32.58 M (-62.15%)
What is Assembly Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ASMB is $28.45 M
What is the all time high quarterly cash and cash equivalents for Assembly Biosciences?
Assembly Biosciences all-time high quarterly cash and cash equivalents is $119.75 M
What is Assembly Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ASMB quarterly cash and cash equivalents has changed by +$1.80 M (+6.74%)